Alembic Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit at API-II Facilty at Panelav for its 8 APIs. The inspection was conducted from September 16, 2024 to September 20, 2024.
Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company.